z-logo
open-access-imgOpen Access
Detection of temozolomide-induced hypermutation and response to PD-1 checkpoint inhibitor in recurrent glioblastoma
Author(s) -
Paul Daniel,
Brian Meehan,
Siham Sabri,
Fatemeh Jamali,
Jann N. Sarkaria,
Dongsic Choi,
Delphine Garnier,
Gaspar J. Kitange,
Kate I. Glen,
Antoine Paccard,
Jason Karamchandani,
Yasser Riazalhosseini,
Janusz Rak,
Bassam Abdulkarim
Publication year - 2022
Publication title -
neuro-oncology advances
Language(s) - English
Resource type - Journals
ISSN - 2632-2498
DOI - 10.1093/noajnl/vdac076
Subject(s) - somatic hypermutation , temozolomide , immune system , immunotherapy , cancer research , biology , immunology , glioma , antibody , b cell

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom